In recognition of Myopia Action Month, Review of Myopia Management joined the global effort to combat the growing myopia epidemic. We spoke...
In six months, Essilor Stellest 2.0 lenses achieved interim results comparable to those previously reported after 12 months with first-generation Essilor Stellest...
September 8, 2026 On Sunday, August 30, 2026, Review of Myopia Management hosted THE Myopia Meeting at the Omni Las Colinas Hotel...
September 1, 2026 ST. LOUIS —The Global Myopia Awareness Coalition (GMAC) announced its 2026-2027 Advisory Panel. Bringing together expertise across myopia research,...
August 28, 2026 — EssilorLuxottica announced 24-month results from the U.S. clinical trial evaluating Essilor Stellest lenses* have been published in JAMA...
Dr. Sandra Ganesh discusses the findings and implications of a recent retrospective cohort study evaluating spectacle lenses for myopia management. August 17,...
June 23, 2026 This video highlights key myopia research and scientific insights presented by EssilorLuxottica at ARVO 2026. Featuring perspectives from international...
May 26, 2026 PARIS — At this year’s Association for Research in Vision and Ophthalmology (ARVO) meeting in Denver, EssilorLuxottica shared its...
May 20, 2026 In celebration of Myopia Awareness Week (May 18–24) and its 2026 theme, “Start Early, Protect Vision for Life,” Review...
April 1, 2026 By Glenda Aleman Moheeputh, OD As U.S. practitioners gain access to myopia control spectacle lenses, many of us are...
March 5, 2026 In this podcast, we discuss the first U.S. FDA‑market authorized spectacle lens for correcting myopia and slowing its progression...
March 2, 2026 PARIS — EssilorLuxottica recently presented at two scientific forums in Hong Kong—the Collaborative Community on Ophthalmic Innovation (CCOI) Asia-Pacific Innovation...
The Global Myopia Awareness Coalition (GMAC) announced its 2026 Board of Directors, bringing together a distinguished group of global leaders dedicated to...
January 5, 2026 By Mark Bullimore, MCOptom, PhD, FAAO When Noel Brennan and I wrote our article, “Myopia Control: Why Each Diopter...
THE Myopia Meeting Markham event recap December 16, 2025 MARKHAM, Ontario, Canada – On Sunday, December 7, leaders in the eye care...
Exploring H.A.L.T.* MAX Technology sponsored content December 16, 2025 By Dr. Björn Drobe, Director of Applied Myopia Research, R&D, EssilorLuxottica Since their...
sponsored content December 4, 2025 By Dr. Jason Shen, Director of Vision Science Research, North America, EssilorLuxottica Dr. Björn Drobe – Director,...
Meet Essilor® Stellest® lenses, the first and only FDA market authorized spectacle lens to slow myopia progression in children.*1 Click here to...
November 19, 2025 ST. LOUIS — Earlier this year, the World Council of Optometry (WCO) hosted the 5th World Congress of Optometry....
November 6, 2025 PARIS, France — EssilorLuxottica announced the Essilor Stellest 2.0 lenses at the China International Import Expo (CIIE) in Shanghai....
October 15, 2025 By Ashley Tucker, OD, FAAO, FSLS, ABO Diplomate The long-anticipated FDA approval of Essilor’s Stellest spectacle lens marks a...


Are you thinking about adding or expanding your myopia management services? Or have you started and stalled? No matter where you are...
sponsored content October 1, 2025 Earlier this year, EssilorLuxottica announced PREMYOM, a five-year research and innovation project designed to set a new...
U.S. eye care professionals can expect the Essilor Stellest lenses to be available in the coming weeks. September 26, 2025 PARIS, France...
Have you been dragging your feet or are you stalled in implementing myopia management? If so, you’re not alone. Jobson Optical Research...
“The start is what stops most people.” –Don Shula Overall, only 23% of myopic patients aged 18 and under are receiving some...
sponsored content June 16, 2025 By Dr. Bryan Sim, Consultant Ophthalmologist, Myopia Service, Singapore National Eye Centre (SNEC) Introduction: Addressing the Challenge...